About The Founder

After accumulating over thirteen years of investment experience on both the buy and sell side of Wall Street, as well as corporate treasury expertise at a major healthcare institution, Guy-Max Delphin founded DI in December 2008. Mr. Delphin heads investment product design and serves as the Chief Investment Officer, responsible for macro/top-down strategy, and fundamental research. Before forming DI, Mr. Delphin was an Investment Strategist leading the investment efforts for the Yale–New Haven Health System; an institution with $1 billion in assets spread across three portfolios: pension, endowment, and operating funds. He also worked at Fortis Investments as a Senior Analyst, responsible for research, and investments in public stocks of the Financial Services sector within the U.S. Equity Team. Prior to Fortis, Mr. Delphin worked at Jefferies & Company, Inc. where he was a Senior Associate of equity research in the Small-Cap Industrials group. Preceding that, he was an Associate Analyst of equity research at Prudential Equity Group, LLC., first in the Small-Cap Quantitative Strategy Group, and then in the Global Consumer Team. Earlier in his career, Mr. Delphin was employed by Oppenheimer Funds, Inc. as a Quantitative Analyst in their Investment Product Design, and Risk Management Group.